Literature DB >> 3258426

Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.

L Jonasson1, J Holm, G K Hansson.   

Abstract

The arterial response to injury is dominated by proliferation of smooth muscle cells and infiltration of blood-borne cells in the vascular intima. Arterial smooth muscle cell proliferation is under growth factor control, but how this regulation operates in vivo is unclear. We studied the effect on arterial response to mechanical injury of cyclosporin A, a drug that inhibits T-lymphocyte activation. Cyclosporin A treatment at surgery caused a persistent inhibition of the intimal proliferative lesion. Cyclosporin A also inhibited expression of Ia antigens on smooth muscle cells in situ but had no direct effects on smooth muscle cell proliferation in culture. Therefore, the inhibition of intimal cell proliferation appears to be mediated via the immune system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258426      PMCID: PMC279979          DOI: 10.1073/pnas.85.7.2303

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  A significant part of macrophage-derived growth factor consists of at least two forms of PDGF.

Authors:  K Shimokado; E W Raines; D K Madtes; T B Barrett; E P Benditt; R Ross
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

2.  Stimulation of oligodendroglial proliferation and maturation by interleukin-2.

Authors:  E N Benveniste; J E Merrill
Journal:  Nature       Date:  1986 Jun 5-11       Impact factor: 49.962

Review 3.  Replication of smooth muscle cells in vascular disease.

Authors:  S M Schwartz; G R Campbell; J H Campbell
Journal:  Circ Res       Date:  1986-04       Impact factor: 17.367

Review 4.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

Review 5.  A reassessment of endothelial injury and arterial lesion formation.

Authors:  M A Reidy
Journal:  Lab Invest       Date:  1985-11       Impact factor: 5.662

6.  Cyclosporine blocks the induction of class I and class II MHC products in mouse kidney by graft-vs-host disease.

Authors:  P Autenried; P F Halloran
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

7.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

Review 8.  Cyclosporine.

Authors:  R J Ptachcinski; G J Burckart; R Venkataramanan
Journal:  Drug Intell Clin Pharm       Date:  1985-02

9.  Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

Authors:  M Kohase; D Henriksen-DeStefano; L T May; J Vilcek; P B Sehgal
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

Review 10.  Cyclosporine: immunology, toxicity and pharmacology in experimental animals.

Authors:  A W Thomson; P H Whiting; J G Simpson
Journal:  Agents Actions       Date:  1984-10
View more
  28 in total

1.  Myocardial protection during coronary angioplasty.

Authors:  P Angelini; D R Leachman; G Disciascio; M J Cowley; J A Brinker
Journal:  Tex Heart Inst J       Date:  1992

Review 2.  Anti-inflammatory therapies for atherosclerosis.

Authors:  Magnus Bäck; Göran K Hansson
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

3.  AIDS-associated Kaposi's sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin.

Authors:  H A Weich; S Z Salahuddin; P Gill; S Nakamura; R C Gallo; J Folkmann
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

4.  Potentiation of vascular smooth muscle cell activity by cyclosporin A.

Authors:  R Locher; R Huss; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  T lymphocytes inhibit the vascular response to injury.

Authors:  G K Hansson; J Holm; S Holm; Z Fotev; H J Hedrich; J Fingerle
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 6.  A journey in science: medical scientist in translation.

Authors:  Göran K Hansson
Journal:  Mol Med       Date:  2014-09-05       Impact factor: 6.354

Review 7.  Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.

Authors:  Charlotte Spitz; Holger Winkels; Christina Bürger; Christian Weber; Esther Lutgens; Göran K Hansson; Norbert Gerdes
Journal:  Cell Mol Life Sci       Date:  2015-10-30       Impact factor: 9.261

8.  Development of intimal lesions after leukocyte migration into the vascular wall.

Authors:  M F Prescott; C K McBride; M Court
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

9.  Balloon catheter de-endothelialization of the nude rat carotid. Response to injury in the absence of functional T lymphocytes.

Authors:  G A Ferns; M A Reidy; R Ross
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

10.  Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury.

Authors:  E R Edelman; D H Adams; M J Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.